Zacks
0
All posts from Zacks
Zacks in Our Research. Your Success.,

Edge Therapeutics (EDGE) in Focus: Stock Rises 6.7%

Edge Therapeutics, Inc. EDGE was a big mover last session, as its shares rose almost 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. Yesterday’s rally continues the recent uptrend for the company, as the stock is now up over 24% in the past one-month time frame.

Over the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Edge Therapeutics currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

A better-ranked biomedical stock is Anika Therapeutics Inc. ANIK with a Zacks Rank #1 (Strong Buy).

Is EDGE going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
ANIKA THERAPEUT (ANIK): Free Stock Analysis Report
 
EDGE THERAPEUTC (EDGE): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research